Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

S&N Preps For Potential Ceramic Hip Launch At March AAOS Meeting

This article was originally published in The Gray Sheet

Executive Summary

Smith & Nephew expects PMA approval of a ceramic-on-ceramic hip by the second quarter of 2004, according to Orthopedics Division President David Illingworth

You may also be interested in...



S&N Adds Birmingham Hip Resurfacing With $179 Mil. MMT Purchase

Smith & Nephew aims to be the first firm to gain U.S. approval for a hip resurfacing device with the Birmingham Hip Resurfacing product, acquired with Midland Medical Technologies March 12

S&N Adds Birmingham Hip Resurfacing With $179 Mil. MMT Purchase

Smith & Nephew aims to be the first firm to gain U.S. approval for a hip resurfacing device with the Birmingham Hip Resurfacing product, acquired with Midland Medical Technologies March 12

Zimmer Integration Effort “Ahead Of Schedule,” Will Cost $79 Mil. In 2004

Zimmer hopes to further differentiate its total knee replacement offerings with the formal launch of its MIS Quad-Sparing minimally-invasive implant procedure at the American Academy of Orthopedic Surgeons meeting March 10-14 in San Francisco

Related Content

UsernamePublicRestriction

Register

MT019685

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel